Randomized Prospective Comparison of Everolimus-Eluting vs. Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Interventionã- 3-Year Clinical Outcomes of the EXCELLENT Randomized Trial.

Park, Kyung Woo; Rhee, Tae-Min; Kang, Hyun-Jae; Koo, Bon-Kwon; Gwon, Hyeon-Cheol; Yoon, Jung-Han; Lim, Do-Sun; Chae, In-Ho; Han, Kyoo-Rok; Ahn, Taehoon; Jeong, Myung-Ho; Jeon, Dong-Woon; Jang, Yang-Soo; Kim, Hyo-Soo

Randomized Prospective Comparison of Everolimus-Eluting vs. Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Interventionã- 3-Year Clinical Outcomes of the EXCELLENT Randomized Trial.

Park, Kyung Woo; Rhee, Tae-Min; Kang, Hyun-Jae; Koo, Bon-Kwon; Gwon, Hyeon-Cheol; Yoon, Jung-Han; Lim, Do-Sun; Chae, In-Ho; Han, Kyoo-Rok; Ahn, Taehoon; Jeong, Myung-Ho; Jeon, Dong-Woon; Jang, Yang-Soo; Kim, Hyo-Soo.

Afiliação

Park KW; Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital.
Rhee TM; Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital.
Kang HJ; Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital.
Koo BK; Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital.
Gwon HC; Sung-Kyun-Kwan University Samsung Medical Center.
Yoon JH; Yonsei University Wonju Severance Hospital.
Lim DS; Korea University Anam Hospital.
Chae IH; Seoul National University Bundang Hospital.
Han KR; Kangdong Sacred Heart Hospital.
Ahn T; Gachon University Gil Medical Center.
Jeong MH; Chonnam National University Hospital.
Jeon DW; NHIC Ilsan Hospital.
Jang YS; Yonsei University Severance Hospital.
Kim HS; Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital.

Circ J ; 82(6): 1566-1574, 2018 05 25.

Article em En | MEDLINE | ID: mdl-28966335

Assuntos

Stents Farmacológicos/normas; Everolimo/administração & dosagem; Intervenção Coronária Percutânea/métodos; Sirolimo/administração & dosagem; Idoso; Stents Farmacológicos/efeitos adversos; Everolimo/efeitos adversos; Everolimo/uso terapêutico; Feminino; Seguimentos; Humanos; Masculino; Pessoa de Meia-Idade; Intervenção Coronária Percutânea/mortalidade; Sirolimo/uso terapêutico; Análise de Sobrevida; Resultado do Tratamento

Palavras-chave

Everolimus; Percutaneous coronary intervention; Sirolimus; Stent

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sirolimo / Stents Farmacológicos / Intervenção Coronária Percutânea / Everolimo Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google